Carbon ion radiation for vaginal or cervix mucosal melanoma
Part of Cancer, Skin clinical trials.
This trial studies whether carbon ion radiation can control mucosal melanoma in the lower female genital tract. It may help by targeting the tumor with high-precision radiation while trying to protect nearby organs like the bladder and rectum.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis by tissue testing (histology) of this specific melanoma type
- The melanoma has not spread to other organs (no metastasis)
- Your tumor does not extend onto the skin, and any lymph node involvement is limited to the groin/pelvis
- You are age 20–80, and your health/ability to function is good (ECOG 0–2)
- The tumor is at least 5 mm away from the bladder and rectum lining
- You have not had radiation therapy before, and you can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a type of internal radiation (cesium implant) to treat cancer that has come back in the vagina after previous pelvic radiation. The goal is to save the organ while treating the cancer.
This study tests giving radiation again to treat a cancer that has returned in the pelvic area (including the groin) when surgery isn’t a good option. It may help control the tumor while trying to protect nearby organs such as the small intestine.
This trial combines radiation, chemotherapy, and internal radiation therapy to treat vaginal cancer. It aims to see if this approach is safe and effective for patients with different stages of the disease.
This trial tests whether carbon ion radiation can safely treat rectal cancer that has come back in the pelvis after you already had radiation before. It may help shrink or control the tumor when other options are limited, but it requires careful timing and spacing from nearby organs.
This trial tests a new treatment that combines immunotherapy (drugs that help your immune system fight cancer) with carbon ion radiation (a precise type of radiation) for people with locally advanced cervical cancer that hasn't spread to other organs. The goal is to see if this combination is safe and effective.
This trial tests a more precise way to deliver radiation for locally advanced cervical cancer using MRI guidance during treatment, along with chemotherapy. It may help shrink tumors more effectively while aiming to reduce side effects by targeting the right areas.
Hear when a new Malignant Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.